Found 5 matching trials
A Phase 1 Trial of CBL0137 in Patients With Metastatic or Unresectable Advanced Solid Neoplasm
PHASE1This is an open-label, multi-center, sequential groups, dose-escalation stu...
Location
Roswell Park Cancer Institute
CBL0137 in Treating Patients With Advanced Extremity Melanoma or Sarcoma
PHASE1This phase I trial studies best dose and side effects of CBL0137 in treatin...
Location
Roswell Park Cancer Institute
CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
PHASE1This phase I/II trial evaluates the best dose, side effects and possible be...
Location
Children's Hospital of Alabama
Study of IV CBL0137 in Previously Treated Hematological Subjects
PHASE1This clinical trial is a Phase 1, open-label, sequential-group, dose-escala...
Location
The Oncology Institute of Hope & Innovation
Study of CBL0137 in Combination With Ipilimumab and Nivolumab Therapy in Melanoma
EARLY_PHASE1Phase I, open label, dose-escalation, and safety study designed to assess t...
Location
Fox Chase Cancer Center